2010
Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study.
Woods SW, Morgenstern H, Saksa JR, Walsh BC, Sullivan MC, Money R, Hawkins KA, Gueorguieva RV, Glazer WM. Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study. The Journal Of Clinical Psychiatry 2010, 71: 463-74. PMID: 20156410, PMCID: PMC3109728, DOI: 10.4088/jcp.07m03890yel.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAmbulatory CareAntipsychotic AgentsCohort StudiesCommunity Mental Health CentersConnecticutDiagnostic and Statistical Manual of Mental DisordersDyskinesia, Drug-InducedFemaleHumansIncidenceLongitudinal StudiesMaleMental DisordersMiddle AgedPrevalenceProspective StudiesPsychiatric Status Rating ScalesRisk FactorsSeverity of Illness IndexConceptsProspective cohort studyConventional antipsychoticsTardive dyskinesiaAtypical antipsychoticsCohort studyPrevious prospective cohort studyCommunity mental health centerConventional antipsychotic medicationsMental health centersAntipsychotic medicationHealth centersBaseline evaluationAntipsychoticsNew diagnosisDyskinesiaClinical practicePsychiatric outpatientsRecent exposureIncidencePrevious visitPrevious studiesPrevalenceSubjectsCurrent studyMost previous studies
2000
Continuation of high-risk behavior by HIV-positive drug users Treatment implications
Avants S, Warburton L, Hawkins K, Margolin A. Continuation of high-risk behavior by HIV-positive drug users Treatment implications. Journal Of Substance Use And Addiction Treatment 2000, 19: 15-22. PMID: 10867296, DOI: 10.1016/s0740-5472(99)00092-6.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHIV risk behaviorsHigh-risk behaviorsLevels of HIVDrug usersHIV-seropositive injection drug usersEffective risk reduction interventionsSex-related HIV risk behaviorsDrug-related risk behaviorsMethadone maintenance treatmentInjection drug usersRisk reduction interventionsHIV seropositive statusRisk Assessment BatteryRisk reduction informationSex-related risksBehavioral skillsHIV serostatusHIV transmissionImmunodeficiency virusMaintenance treatmentPsychiatric severityRisk behaviorsTreatment implicationsAssessment Battery